Pauric Bannigan, Intrepid Labs, explains where AI speeds formulation decisions, why data is the bottleneck, and how active learning trains models with far less data.

Stephanie Johnson, Pfizer, explains how off-platform triggers, single-owner risk registers, and traceable prior knowledge keep protein formulation programs on track. Stephanie Johnson, Pfizer, ...

Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these ...

Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.

The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.

The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of ...

The scope covers prescription drugs and drug-led, drug-device combination products where the Center for Drug Evaluation and ...

Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, ...

Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go ...

Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to ...

OpenAI acquired Orchestra Bio to pair AI agents that track drug development timelines with its Rosalind life sciences tools, ...

This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ...